From The Corner Lab - Blog Posts

Major Cancer Center Say No To New Cancer Med. Rationale Or Rationing?

Posted by Jim Menoutis on Mon, Oct 15, 2012 @ 03:43 PM

With all the talk of rising prices for cancer medications, the cost of healthcare and comparing the value and benefit of competing drugs, Memorial Sloan-Kettering Cancer Center has decided not to use a newly approved treatment for metastatic colorectal cancer. The leading hospital says it will exclude the new colorectal cancer drug Zaltrap which is marketed by Sanofi and Regeneron, from its treatment protocol.  

Read More

Topics: Roche, Zaltrop, treatment protocol, Sanofi, Cancer Treatment, Avastin, Regeneron, medical rationing, healthcare rationing